| 1,090 | 80 | 55 |
| 下载次数 | 被引频次 | 阅读次数 |
随着指南定义的更新及方法学的发展,国内外发布的指南数量不断增多,但其质量良莠不齐,各个国际指南组织也针对这一问题制定了高质量循证指南的原则和标准,同时出版指南制定手册阐述严谨透明的步骤和方法。本文基于国内外经验,总结了中国指南制定面临的机遇和挑战,并提出改进建议:政府、协会/学会层面倡导循证实践指南的制定;加强指南的研究与合作;注重指南的注册与评审。
Abstract：With the update of definition of practice guideline and the development of guideline methodology,more and more practice guidelines were published in China and abroad,however,the guidelines is of varying quality.To improve the practice guidelines,many international guideline organizations developed the criteria and standards for high-quality evidence-based practice guidelines,and published guideline development handbooks describing rigorous and transparent steps and methods.Based on the experience of developing guidelines from China and abroad,this article summarized the opportunities and challenges of the guideline development China are facing,and proposed three strategies for the improvement:to advocate the development of guideline from the perspective of government and professional societies/associations;to strength the research and cooperation on guideline;to pay attention to the registration and review of guidelines.
[1]Institute of Medicine.Clinical practice guidelines:directions for a new program[M].Washington,DC:National Academy Press,1990.
[2]詹思延.临床实践指南的制定应该科学、规范[J].中华儿科杂志,2009,47(3):163-166.
[3]Institute of Medicine.Clinical practice guidelines we can trust[M].Washington,DC:National Academies Press,2011.
[4]World Health Organization.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection[M].Geneva:WHO Press,2013.
[5]Schunemann H J,Wiercioch W,Etxeandia I,et al.Guidelines 2.0:systematic development of a comprehensive checklist for a successful guideline enterprise[J].CMAJ,2014,186(3):e123-142.
[6]胡晶,陈茹,谢雁鸣,等.科学和规范的改编临床实践指南[J].中国循证儿科杂志,2012,7(3):226-230.
[7]Brouwers M C,Kho M E,Browman G P,et al.AGREEⅡ:advancing guideline development,reporting and evaluation in health care[J].Canadian Medical Association Journal,2010,182(18):e839-842.
[8]Chen Yao-long,Yao Liang,Xiao Xiao-juan,et al.Quality assessment of clinical guidelines in China:1993-2010[J].Chin Med J(Engl),2012,125(20):3660-3664.
[9]Yang Ke-hu,Chen Yao-long,Li You-ping,et al.Editorial:can China master the guideline challenge?[J/OL].Health Res Policy Syst,2013,11(1)[2015-12-30].http://www.health-policy-systems.com/content/11/1/1.
[10]韦当,王小琴,吴琼芳,等.2011年中国临床实践指南质量评价[J].中国循证医学杂志,2013,13(6):760-763.
[11]Qaseem A,Forland F,Macbeth F,et al.Guidelines International Network:toward international standards for clinical practice guidelines[J].Ann Intern Med,2012,156(7):525-531.
[12]National Institute for Health and Clinical Excellence.Process and methods guides:the guidelines manual[M].2012.https://www.nice.org.uk/article/pmg6/chapter/1.
[13]World Health Organization.WHO handbook for guideline development[M].Geneva:WHO Press,2015.
[14]Schunemann H J,Al-Ansary LA,Forland F,et al.Guidelines International Network:principles for disclosure of Interests and management of conflicts in guidelines[J].Ann Intern Med,2015,163(7):548-553.
[15]Guyatt G,Oxman A D,Akl E A,et al.GRADE guidelines:1.introduction-GRADE evidence profiles and summary of findings tables[J].J Clin Epidemiol,2011,64(4):383-394.
[16]陈耀龙.卫生保健实践指南的报告规范研究[D].兰州:兰州大学基础医学院,2015.
[17]Alonso-Coello P,Martinez Garcia L,Carrasco J M,et al.The updating of clinical practice guidelines:insights from an international survey[J/OL].Implement Sci,2011,6(107)[2015-12-30].http://www.implementationscience.com/content/6/l/107.
[18]杨梅,林丽星,张志玲,等.苯巴比妥治疗新生儿缺氧缺血性脑病的系统评价[J].兰州大学学报:医学版,2009,35(1):38-42.
[19]贾鹤龄,张彬,张斌飞,等.皮质类固醇在体外循环下小儿心脏手术中作用的Meta分析[J].兰州大学学报:医学版,2011,37(4):50-53.
[20]崔树起,梁万年.临床指南实用手册[M].北京:人民卫生出版社,2003.
[21]Guyatt G H,Oxman A D,Kunz R,et al.GRADE guidelines:2.framing the question and deciding on important outcomes[J].J ClinEpidemiol,2011,64(4):395-400.
[22]Balshem H,Helfand M,Schunemann H J,et al.GRADE guidelines:3.rating the quality of evidence[J].J Clin Epidemiol,2011,64(4):401-406.
[23]Guyatt G H,Oxman A D,Vist G,et al.GRADE guidelines:4.rating the quality of evidence-study limitations(risk of bias)[J].J Clin Epidemiol,2011,64(4):407-415.
[24]Guyatt G H,Oxman A D,Montori V,et al.GRADE guidelines:5.rating the quality of evidence-publication bias[J].J Clin Epidemiol,2011,64(12):1277-1282.
[25]Guyatt G H,Oxman A D,Kunz R,et al.GRADE guidelines 6.rating the quality of evidence-imprecision[J].Journal of clinical epidemiology,2011,64(12):1283-1293.
[26]Guyatt G H,Oxman A D,Kunz R,et al.GRADE guidelines:7.rating the quality of evidence-inconsistency[J].J Clin Epidemiol,2011,64(12):1294-1302.
[27]Guyatt G H,Oxman A D,Kunz R,et al.GRADE guidelines:8.rating the quality of evidence-indirectness[J].J Clin Epidemiol,2011,64(12):1303-1310.
[28]Guyatt G H,Oxman A D,Sultan S,et al.GRADE guidelines:9.rating up the quality of evidence[J].J Clin Epidemiol,2011,64(12):1311-1316.
[29]Brunetti M,Shemilt I,Pregno S,et al.GRADE guidelines:10.considering resource use and rating the quality of economic evidence[J].J Clin Epidemiol,2013,66(2):140-150.
[30]Guyatt G H,Oxman A D,Sultan S,et al.GRADE guidelines:11.making an overall rating of confidence in effect estimates for a single outcome and for all outcomes[J].J Clin Epidemiol,2013,66(2):151-157.
[31]Guyatt G H,Oxman A D,Santesso N,et al.GRADE guidelines:12.preparing summary of findings tables-binary outcomes[J].J Clin Epidemiol,2013,66(2):158-172.
[32]Guyatt G H,Thorlund K,Oxman A D,et al.GRADE guidelines:13.preparing summary of findings tables and evidence profiles-continuous outcomes[J].J Clin Epidemiol,2013,66(2):173-183.
[33]Andrews J,Guyatt G H,Oxman A D,et al.GRADE guidelines:14.going from evidence to recommendations:the significance and presentation of recommendations[J].J Clin Epidemiol,2013,66(7):719-725.
[34]Andrews J C,Schunemann H J,Oxman A D,et al.GRADE guidelines:15.going from evidence to recommendation-determinants of a recommendation's direction and strength[J].J Clin Epidemiol,2013,66(7):726-735.
[35]Guyatt G H,Oxman A D,Vist G E,et al.GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ,2008,336(7650):924-926.
[36]吕爱平,谢雁鸣,韩学杰.基于循证医学的中医临床实践指南编制方法和范例[M].北京:中国中医药出版社,2013.
[37]Guyatt G H.循证医学的五个发展方向[J].中国循证医学杂志,2006,6(3):175-161.
[38]Evidence-Based Medicine Working Group.Evidencebased medicine:a new approach to the teaching of medicine[J].JAMA,1992,268(17):2420-2425.
[39]Alonso-Coello P,Montori V M,Sola I,et al.Values and preferences in oral anticoagulation in patients with atrial fibrillation,physicians'and patients'perspectives:protocol for a two-phase study[J].BMC Health Serv Res,2008,8:221.
[40]Holbrook A,Labiris R,Goldsmith C H,et al.Influence of decision aids on patient preferences for anticoagulant therapy:a randomized trial[J].CMAJ,2007,176(11):1583-1587.
[41]Man-Son-Hing M,Laupacis A,O'Connor A M,et al.A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation:a randomized controlled trial[J].JAMA,1999,282(8):737-743.
[42]O'Meara J J I,McNutt R A,Evans A T,et al.A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis[J].N Engl J Med,1994,330(26):1864-1869.
[43]解染,陈耀龙,陈吴,等.循证指南制定中患者价值观和偏好的研究方法[J].中国循证医学杂志,2015,15(5):586-591.
基本信息:
DOI：10.13885/j.issn.1000-2812.2016.01.006
中图分类号:R-03
引用信息:
[1]陈耀龙,杨克虎,田金徽等.循证实践指南的制定:国际经验与中国实践[J].兰州大学学报(医学版),2016,42(01):29-35.DOI:10.13885/j.issn.1000-2812.2016.01.006.
基金信息:
国家自然科学基金青年项目(81503459);; 中央高校基本科研业务费专项资金项目(lzujbky-2014-k18)